David S. Weinstein - Concepedia

Author

David S. Weinstein

Bristol-Myers Squibb (United States)ORCID

Also Known As

D WEINSTEIN, D Weinstein, D. S. WEINSTEIN, D. S. Weinstein, D. Weinstein, D.S. WEINSTEIN, David S Weinstein, David S. Weinstein, David Weinstein, Weinstein, David S.

Publications

2.8K

Citations

H-Index

Concepts

All Affiliations

Bristol-Myers Squibb (United States)La Roche College Bristol-Myers Squibb (Germany)Vividion Therapeutics (United States)Bristol-Myers Squibb (Sweden)

About

David S. Weinstein is an author at Bristol-Myers Squibb (United States) specializing in medicine, biochemistry, and natural sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	20	839
2	Natural Sciences	12	12	592
3	Engineering	3	3	177
4	Health Sciences	1	1	30
5	Public Health	1	1	30

David S. Weinstein

Publications

2.2K

Citations

H-Index

Page 1

	Year	Citations
Highly Selective Inhibition of Tyrosine Kinase 2 (TYK2) for the Treatment of Autoimmune Diseases: Discovery of the Allosteric Inhibitor BMS-986165 Stephen T. Wrobleski, Ryan Moslin, Shuqun Lin, Journal of Medicinal Chemistry	2019	345
Autoimmune pathways in mice and humans are blocked by pharmacological stabilization of the TYK2 pseudokinase domain James R. Burke, Lihong Cheng, Kathleen M. Gillooly, Science Translational Medicine	2019	268
DCAF11 Supports Targeted Protein Degradation by Electrophilic Proteolysis-Targeting Chimeras Xiaoyu Zhang, Lena Luukkonen, Christie L. Eissler, Journal of the American Chemical Society Proteomic TechnologyAndrogen ReceptorProtein FunctionBiochemistryProtein Assembly	2021	183
C<sub>60</sub> and C<sub>70</sub> in a Basket? – Investigations of Mono‐ and Multilayers from Azacrown Compounds and Fullerenes Joehem Effing, Ulrich Jonas, Ludovic Jullien, Angewandte Chemie International Edition in English Materials ScienceSurface Pressure-area DiagramsEngineeringElectronic MaterialsFullerene Molecules	1992	139
Levels of platelet calmodulin for the prediction of progression and severity of adolescent idiopathic scoliosis. K Kindsfater, Tim E. Lowe, David W. Lawellin, Journal of Bone and Joint Surgery Control GroupSpinal Cord InjuryCardiovascular DiseaseSkeletal MuscleMedicine	1994	133
Tyrosine Kinase 2-mediated Signal Transduction in T Lymphocytes Is Blocked by Pharmacological Stabilization of Its Pseudokinase Domain John S. Tokarski, Adriana Zupa-Fernandez, Jeffrey Tredup, Journal of Biological Chemistry	2015	112
Chemoproteomic discovery of a covalent allosteric inhibitor of WRN helicase Kristen A. Baltgalvis, Kelsey N. Lamb, Kent T. Symons, Nature Molecular RecognitionBiochemistryNatural SciencesEnzyme CatalysisMolecular Biology	2024	88
Identification of <i>N</i>-Methyl Nicotinamide and <i>N</i>-Methyl Pyridazine-3-Carboxamide Pseudokinase Domain Ligands as Highly Selective Allosteric Inhibitors of Tyrosine Kinase 2 (TYK2) Ryan Moslin, Yanlei Zhang, Stephen T. Wrobleski, Journal of Medicinal Chemistry	2019	84
Discovery of BMS-986202: A Clinical Tyk2 Inhibitor that Binds to Tyk2 JH2 Chunjian Liu, James C. Lin, Charles M. Langevine, Journal of Medicinal Chemistry	2020	76
Azaxanthene Based Selective Glucocorticoid Receptor Modulators: Design, Synthesis, and Pharmacological Evaluation of (<i>S</i>)-4-(5-(1-((1,3,4-Thiadiazol-2-yl)amino)-2-methyl-1-oxopropan-2-yl)-5<i>H</i>-chromeno[2,3-<i>b</i>]pyridin-2-yl)-2-fluoro-<i>N</i>,<i>N</i>-dimethylbenzamide (BMS-776532) and Its Methylene Homologue (BMS-791826) David S. Weinstein, Hua Gong, Arthur M. Doweyko, Journal of Medicinal Chemistry ImmunologyWhole BloodPharmacotherapyPharmaceutical ChemistryInflammation	2011	55

Page 1